Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions

Wednesday, July 28, 2021

An ongoing strategic growth plan from Cytiva and Pall Corporation part of the Danaher Corporation will expand manufacturing capacity and services across geographies for global life sciences customers The investment already underway includes new sites...

Scipher Medicine Increases Patient Access for PrismRA® by Expanding Intended Use in Autoimmune Patients

Friday, July 30, 2021

Scipher Medicine a precision immunology company matching patients with most effective therapy today announced the expanded clinical utility and intended use to include most rheumatoid arthritis RA patients for its commercially available PrismRA blood...

US FDA grants VICO Therapeutics Orphan-Drug Designation for VO659, an Investigational Therapy for Huntington Disease

Thursday, July 29, 2021

VICO Therapeuticsa Leiden Bio Science Park the Netherlands based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders today announced that the Office of Orphan Products Development OOPD of the US Foo...

Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses

Thursday, July 29, 2021

Loxo Oncology at Lilly a research and development group of Eli Lilly and Company NYSE LLY and Kumquat Biosciences today announced an exclusive collaboration focused on the discovery development and commercialization of potential novel small molecules...

Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs

Friday, July 30, 2021

Minovia Therapeutics Ltd CEO Natalie YivgiOhana PhD Minovia and Astellas Pharma Inc TSE President and CEO Kenji Yasukawa PhD Astellas today announced a worldwide strategic collaboration and license agreement for the research development and commerc...

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

Thursday, July 29, 2021

Allergan an AbbVie company today announced that the US Food and Drug Administration FDA has approved a label expansion of BOTOX to include eight new muscles for the treatment of upper limb spasticity in adults The new muscles for treatment include ad...

FDA accepts application for Roche’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)

Thursday, July 29, 2021

Roche today announced that the US Food and Drug Administration FDA has accepted the companys Biologics License Application BLA under Priority Review for faricimab for the treatment of neovascular or wet agerelated macular degeneration nAMD and diabet...

Turkish Cargo Has Been Carrying Turkish Rose Products to All Over the World for the Last Half Century

Friday, July 30, 2021

Possessing the worlds strongest cargo flight network and building the trade bridges between continents Turkish Cargo also contributes greatly to Turkeys exports For over the last years Flag carrier air cargo brand has been carrying the rose products...

Tillotts Pharma AG announces launch of Asacol® 800 mg Tablets in the People’s Republic of China

Thursday, July 29, 2021

Tillotts Pharma AG part of the Japanese Zeria Group is pleased to announce the recent launch of Asacol mg tablets mesalazine as firstline treatment for mild to moderate ulcerative colitis UC in the Peoples Republic of China China After announcing th...

Protagonist Therapeutics Announces Amendment of Agreement with Janssen Biotech for the Continued Development and Commercialization of IL-23 Antagonists

Wednesday, July 28, 2021

Protagonist Therapeutics Inc today announced its entry into an amended collaboration agreement the Restated Agreement with Janssen Biotech Inc one of the Janssen Pharmaceutical Companies of Johnson Johnson relating to research development manufactur...